155 related articles for article (PubMed ID: 11811564)
1. Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells.
Chen XD; Shi S; Xu T; Robey PG; Young MF
J Bone Miner Res; 2002 Feb; 17(2):331-40. PubMed ID: 11811564
[TBL] [Abstract][Full Text] [Related]
2. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
3. Biglycan-deficient mice have delayed osteogenesis after marrow ablation.
Chen XD; Allen MR; Bloomfield S; Xu T; Young M
Calcif Tissue Int; 2003 May; 72(5):577-82. PubMed ID: 12724831
[TBL] [Abstract][Full Text] [Related]
4. Dissection of the sets of genes that control the behavior of biglycan-deficient pre-osteoblasts using oligonucleotide microarrays.
Chen XD; Bian X; Teslovich TM; Stephan DA; Young MF
Bone; 2005 Aug; 37(2):192-203. PubMed ID: 15922682
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.
Corsi A; Xu T; Chen XD; Boyde A; Liang J; Mankani M; Sommer B; Iozzo RV; Eichstetter I; Robey PG; Bianco P; Young MF
J Bone Miner Res; 2002 Jul; 17(7):1180-9. PubMed ID: 12102052
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice.
Xu T; Bianco P; Fisher LW; Longenecker G; Smith E; Goldstein S; Bonadio J; Boskey A; Heegaard AM; Sommer B; Satomura K; Dominguez P; Zhao C; Kulkarni AB; Robey PG; Young MF
Nat Genet; 1998 Sep; 20(1):78-82. PubMed ID: 9731537
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment.
Chen TL
Bone; 2004 Jul; 35(1):83-95. PubMed ID: 15207744
[TBL] [Abstract][Full Text] [Related]
8. The mechanical phenotype of biglycan-deficient mice is bone- and gender-specific.
Wallace JM; Rajachar RM; Chen XD; Shi S; Allen MR; Bloomfield SA; Les CM; Robey PG; Young MF; Kohn DH
Bone; 2006 Jul; 39(1):106-16. PubMed ID: 16527557
[TBL] [Abstract][Full Text] [Related]
9. Biglycan is required for adaptive remodeling after myocardial infarction.
Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of two small leucine-rich proteoglycans, biglycan and decorin, excerpts divergent effects on enamel and dentin formation.
Goldberg M; Septier D; Rapoport O; Iozzo RV; Young MF; Ameye LG
Calcif Tissue Int; 2005 Nov; 77(5):297-310. PubMed ID: 16283572
[TBL] [Abstract][Full Text] [Related]
11. Preliminary characterization of porcine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor.
Thomson BM; Bennett J; Dean V; Triffitt J; Meikle MC; Loveridge N
J Bone Miner Res; 1993 Oct; 8(10):1173-83. PubMed ID: 8256654
[TBL] [Abstract][Full Text] [Related]
12. Age-related bone loss. A hypothesis and initial assessment in mice.
Kahn A; Gibbons R; Perkins S; Gazit D
Clin Orthop Relat Res; 1995 Apr; (313):69-75. PubMed ID: 7641500
[TBL] [Abstract][Full Text] [Related]
13. Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice.
Gazit D; Zilberman Y; Turgeman G; Zhou S; Kahn A
J Cell Biochem; 1999 Jun; 73(3):379-89. PubMed ID: 10321837
[TBL] [Abstract][Full Text] [Related]
14. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.
Chen XD; Fisher LW; Robey PG; Young MF
FASEB J; 2004 Jun; 18(9):948-58. PubMed ID: 15173106
[TBL] [Abstract][Full Text] [Related]
15. The effect of glucocorticoid on the synthesis of biglycan and decorin in human osteoblasts and bone marrow stromal cells.
Kimoto S; Cheng SL; Zhang SF; Avioli LV
Endocrinology; 1994 Dec; 135(6):2423-31. PubMed ID: 7988427
[TBL] [Abstract][Full Text] [Related]
16. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.
Hirasawa H; Tanaka S; Sakai A; Tsutsui M; Shimokawa H; Miyata H; Moriwaki S; Niida S; Ito M; Nakamura T
J Bone Miner Res; 2007 Jul; 22(7):1020-30. PubMed ID: 17388726
[TBL] [Abstract][Full Text] [Related]
17. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
18. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
Lecanda F; Avioli LV; Cheng SL
J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 stimulates hematopoiesis in murine osteogenic stroma.
Van Vlasselaer P; Falla N; Van Den Heuvel R; Dasch J; de Waal Malefijt R
Clin Orthop Relat Res; 1995 Apr; (313):103-14. PubMed ID: 7641467
[TBL] [Abstract][Full Text] [Related]
20. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells.
Takeuchi Y; Fukumoto S; Matsumoto T
J Cell Physiol; 1995 Mar; 162(3):315-21. PubMed ID: 7860639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
